Oracle Corporation
ORCL
$128.23
-4.64%
Oracle Corporation is a global enterprise technology company that sells database management software, enterprise applications (ERP, HCM, CX), and—increasingly—cloud infrastructure and platform services through on-premises, hybrid, and public cloud deployment models. Founded in 1977 and the pioneer of the commercial SQL relational database, Oracle holds a deeply entrenched position in mission-critical transaction processing for the world's largest enterprises, and it has repositioned itself as a scaled AI-infrastructure and cloud platform contender built on its Oracle Cloud Infrastructure (OCI) franchise. The current investor narrative is dominated by the tension between explosive AI-driven demand—a record $664 billion cloud backlog and roughly 121% infrastructure growth cited in recent coverage—and the balance-sheet cost of capturing it, with capital expenditures running at unprecedented levels and free cash flow deeply negative. Bulls frame Oracle as a top-tier AI infrastructure play with multi-year revenue conversion ahead; bears point to a stock down roughly 60% from its high, ballooning debt, margin dilution from consumption-based cloud database pricing, and questions about AI monetization following softer OpenAI revenue data. The debate has become a referendum on whether Oracle's backlog converts to profitable revenue on schedule before financing costs and capex intensity erode the equity story.…
ORCL
Oracle Corporation
$128.23
Related headlines
Investment Opinion: Should I buy ORCL Today?
Rating: Hold. Oracle's investment thesis is a high-stakes bet on the conversion of its $664 billion cloud backlog into profitable revenue, but the near-term financials are deteriorating. The analyst consensus is 'buy' with a mean rating of 1.58 and an average target of $237.36 (implying +85% upside), yet the stock's -59% one-year decline and negative free cash flow of -$28.7 billion suggest the market is pricing in significant execution risk. We recommend a Hold until there is clearer evidence of margin stabilization and positive free cash flow.
The supporting evidence is mixed. On the positive side, revenue growth is accelerating at 29.6% YoY, forward PE of 11.67x is attractive if EPS estimates of $27.84 are met, and the $664 billion backlog provides multi-year visibility. However, gross margin has fallen from 67.3% to 60.0% over four quarters, TTM free cash flow is -$28.7 billion, and debt-to-equity is 3.67x. The PEG ratio of 1.26 is reasonable, but the trailing PE of 41.78x is above the historical median, and the PS ratio of 10.60x, while below 2025 highs, remains elevated for a hardware-heavy mix.
The biggest risks that could invalidate the thesis are: (1) further margin compression if cloud infrastructure pricing remains competitive, (2) a delay in backlog conversion that forces additional equity or debt issuance, and (3) a broader AI spending slowdown. We would upgrade to Buy if free cash flow turns positive and gross margin stabilizes above 60%, or if the stock price falls below $110 (analyst low target) with no deterioration in fundamentals. We would downgrade to Sell if revenue growth decelerates below 20% or if debt-to-equity exceeds 4.5x. Relative to its history and peers, ORCL appears fairly valued on forward earnings but expensive on trailing metrics, reflecting the market's optimistic backlog conversion assumptions.
Sign up to view all
ORCL 12-Month Price Forecast
Oracle presents a classic tug-of-war between a compelling long-term AI infrastructure story and deteriorating near-term financials. The $664 billion backlog and 29.6% revenue growth are impressive, but negative free cash flow, rising debt, and margin compression are red flags that cannot be ignored. The stock's 59% decline has priced in significant pessimism, yet the forward PE of 11.67x offers little margin of safety if earnings estimates are not met. We would upgrade to bullish if free cash flow turns positive and gross margin stabilizes above 60%, or if the stock falls below $110 with no fundamental deterioration. We would downgrade to bearish if revenue growth decelerates below 20% or if debt-to-equity exceeds 4.5x.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Oracle Corporation's 12-month outlook, with a consensus price target around $237.36 and implied upside of +85.1% versus the current price.
Average Target
$237.36
0 analysts
Implied Upside
+85.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$110 - $400
Analyst target range
Coverage is broad and overwhelmingly bullish: 41 analysts cover Oracle with a consensus recommendation of "buy" and a mean rating of 1.5814 (where 1.0 is a strong buy), and the average target price of $237.36 implies roughly +85% upside from the current $128.23. Recent institutional ratings are uniformly constructive—Freedom Broker, Argus Research, Stifel, Guggenheim, UBS, TD Cowen, and DA Davidson all reiterated Buy, BMO reiterated Outperform, while Stephens & Co. and RBC Capital maintained Equal Weight/Sector Perform—with no downgrades in the September 2026 slate. The consensus is clearly bullish and sees the sell-off as overdone relative to the $664 billion backlog and 29.6% revenue growth, though the gap between the bullish consensus and the stock's -59% one-year performance highlights a significant disconnect between analyst conviction and market pricing. The target range is extraordinarily wide—from a low of $110.00 (about -14% downside) to a high of $400.00 (roughly +212% upside)—signaling very high uncertainty and low conviction on terminal outcomes. The high target assumes flawless backlog conversion, sustained ~30% growth, margin stabilization, and multiple expansion back toward prior highs; the low target of $110.00, just below the 52-week low of $114.50, prices in margin compression, delayed AI revenue conversion, financing stress from negative free cash flow, and competitive losses in cloud infrastructure. The wide spread, combined with a 1.77 beta and a stock trading near its 52-week low, means analyst targets should be treated as scenario markers rather than precise price forecasts; the consensus average of $237.36 is best read as the bull-case anchor, and investors should weigh it against the credible bear case embedded in the $110 low target.
Drowning in data?
Find the real signal!
Bulls vs Bears: ORCL Investment Factors
The bear case currently has stronger near-term evidence: free cash flow of -$28.7 billion, gross margin down 725 basis points year-over-year, debt-to-equity of 3.67x, and a stock down 59% with no technical base. However, the bull case is not without merit—revenue growth of 29.6% and a $664 billion backlog provide a credible path to the $27.84 EPS that would make the 11.67x forward PE look cheap. The single most important tension is whether Oracle can convert its backlog to profitable revenue before financing costs and capex intensity erode the equity story; resolution of this question will determine whether the stock is a deep-value opportunity or a value trap.
Bullish
- Revenue accelerating at 29.6% YoY: Fiscal Q1 2027 revenue reached $19.345 billion, up 29.61% from $14.926 billion a year ago, marking the fifth consecutive quarter of sequential growth. This acceleration is the strongest evidence that the $664 billion cloud backlog is beginning to convert into reported revenue.
- Massive $664B backlog underpins growth: Oracle's cloud backlog stands at a record $664 billion, with infrastructure growth of roughly 121% cited in recent coverage. If even a fraction converts on schedule, it provides multi-year revenue visibility that few large-cap peers can match.
- Forward PE of 11.67x is deeply discounted: The stock trades at 11.67x forward earnings versus a trailing PE of 41.78x, implying the market expects EPS to roughly triple to $27.84. For a company growing revenue at 29.6%, that forward multiple is inexpensive if execution holds.
- Analyst consensus overwhelmingly bullish: 41 analysts rate ORCL a 'buy' with a mean rating of 1.58 (1.0 = strong buy) and an average target of $237.36, implying +85% upside from $128.23. No downgrades appeared in the September 2026 slate, suggesting the sell-off is viewed as overdone.
Bearish
- Free cash flow deeply negative at -$28.7B: TTM free cash flow is -$28.72 billion, driven by Q1 2027 capex of $28.499 billion against operating cash flow of $23.103 billion. The company is funding the gap with $19.9 billion of stock issuance and $13.1 billion of net financing, making growth dependent on external capital.
- Gross margin compression from 67% to 60%: Gross margin has fallen from 67.28% in Q1 2026 to 60.03% in Q1 2027 as lower-margin infrastructure revenue grows. This mix shift erodes the software-like economics that historically justified a premium multiple.
- Leverage is elevated and rising: Debt-to-equity stands at 3.67x and the current ratio is a thin 1.115, while interest expense rose to $1.428 billion in Q1 2027 from $923 million a year earlier. ROE of 40.2% is inflated by leverage, with ROA of just 6.36% revealing capital intensity.
- Stock in severe downtrend, -59% in 1 year: ORCL is down 59.03% over the past year and 34.48% YTD, massively underperforming the S&P 500's +15.53% and +11.93%. At $128.23 it sits just 7.5% above its 52-week low of $114.50, with a -64.96% max drawdown signaling a falling-knife profile.
ORCL Technical Analysis
Oracle is in a severe, sustained downtrend: the stock is down 59.03% over the past year and 34.48% year-to-date, a staggering underperformance versus the S&P 500's +15.53% 1-year and +11.93% YTD returns (relative strength of -74.56 and -46.41, respectively). At $128.23, the shares sit just 7.5% above the 52-week low of $114.50 and 57.9% below the 52-week high of $304.28—only about 7.3% of the way up the 52-week range. That positioning near the bottom of the range, combined with a -64.96% max drawdown, signals a falling-knife profile rather than a value opportunity; there is no evidence yet of a durable base, and the long-term trend remains decisively negative. Recent momentum is mixed but net negative: the 1-month change is -10.43% and the 6-month change is -26.75%, while the 3-month change is a modest +1.44%, suggesting a brief stabilization in July–September that has since rolled over. The 1-month relative strength of -11.65 versus SPY's +1.22% shows the stock is diverging sharply from a rising market—a bearish signal that the recent bounce failed. The most recent session fell 4.64% on elevated volume of roughly 36.0 million shares, indicating distribution rather than accumulation; the 3-month positive print against a negative 1-year trend looks like a failed mean-reversion rally within a primary downtrend. Key levels are clear: support sits at the 52-week low of $114.50, and a breakdown below that would likely trigger momentum-driven selling and open a new leg lower, while resistance is the 52-week high of $304.28—far out of reach—with intermediate resistance around the $150–$160 area where the stock repeatedly failed in August and September. With a beta of 1.77, Oracle is roughly 77% more volatile than the market, meaning position sizing must be materially smaller than a market-weight allocation and stop-loss discipline is critical; a 1.77 beta amplifies both the downside risk of a support breach and any upside from a confirmed reversal.
Beta
1.77
1.77x market volatility
Max Drawdown
-65.0%
Largest decline past year
52-Week Range
$115-$289
Price range past year
Annual Return
-59.0%
Cumulative gain past year
| Period | ORCL Return | S&P 500 |
|---|---|---|
| 1m | -10.4% | +0.2% |
| 3m | +1.4% | +2.9% |
| 6m | -26.8% | +8.4% |
| 1y | -59.0% | +14.9% |
| ytd | -34.5% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ORCL Fundamental Analysis
Revenue is accelerating sharply: fiscal Q1 2027 (quarter ended 2026-08-31) revenue reached $19.345 billion, up 29.61% year-over-year from $14.926 billion in the year-ago quarter, and up sequentially from $19.184 billion in Q4 2026 and $17.190 billion in Q3 2026. The segment mix shows the Cloud and License business at $17.157 billion (roughly 88.7% of the $19.345 billion total), dwarfing Hardware at $774 million and Services at $1.414 billion—confirming that cloud is the sole engine of growth and the legacy hardware/services lines are immaterial to the trajectory. The multi-quarter trend is one of clear acceleration (Q1 2026 revenue of $14.926 billion grew to $16.058 billion in Q2, $17.190 billion in Q3, $19.184 billion in Q4, and $19.345 billion in Q1 2027), consistent with the reported $664 billion cloud backlog; the investment case hinges entirely on whether this backlog converts to revenue on schedule, and the accelerating top line is the strongest evidence for the bull thesis. Profitability remains solid but is being diluted by the cloud mix shift: Q1 2027 net income was $4.760 billion on a 24.61% net margin, with gross margin of 60.03%—down from 65.18% in Q4 2026, 64.56% in Q3 2026, and 67.28% in Q1 2026, a clear compression trend as lower-margin infrastructure revenue grows. Operating income was $6.728 billion (34.78% operating margin) and EBITDA $10.393 billion (53.72% EBITDA margin), so the company is highly profitable in absolute terms, but the gross-margin slide from ~67% to ~60% over four quarters is the key warning sign that consumption-based cloud database and OCI pricing is eroding the historically software-like margin structure. The company remains profitable with a 25.37% net margin and 30.85% operating margin on a TTM basis, but the direction of travel on margins is negative and directly tied to the AI infrastructure buildout. The balance sheet is the central risk: debt-to-equity stands at 3.67x, the current ratio is a thin 1.115, and free cash flow TTM is -$28.72 billion, driven by Q1 2027 capital expenditures of $28.499 billion against operating cash flow of $23.103 billion (quarterly FCF of -$5.396 billion). ROE of 40.20% looks impressive but is inflated by leverage (equity multiplier above 6x), while ROA of just 6.36% reveals the underlying capital intensity; the company funded the gap with $19.909 billion of common stock issuance and $13.111 billion of net financing in Q1 2027, meaning growth is currently dependent on external capital rather than internal cash generation. Cash of $38.934 billion provides a buffer, but with capex at roughly 147% of quarterly operating cash flow, Oracle's financial risk profile has shifted materially from a cash-cow software company to a leveraged infrastructure builder—the single most important fundamental variable for investors to monitor.
Quarterly Revenue
$19.3B
2026-08
Revenue YoY Growth
+29.6%
YoY Comparison
Gross Margin
60.0%
Latest Quarter
Free Cash Flow
$-28.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ORCL Overvalued?
Because Oracle is profitable (Q1 2027 net income of $4.760 billion; TTM net margin 25.37%), the PE ratio is the appropriate primary metric. The trailing PE is 41.78x versus a forward PE of 11.67x—an extraordinarily wide gap that implies the market expects earnings to roughly triple, consistent with consensus EPS estimates of $27.84 versus the current TTM EPS of about $3.07. That forward multiple is the crux of the valuation debate: if the backlog converts and earnings scale as forecast, 11.67x forward earnings is cheap for a 29.6% grower; if conversion slips or margins compress further, the trailing 41.78x is expensive. The PEG ratio of 1.26 suggests the growth-adjusted trailing multiple is not egregious, but it relies heavily on the forward earnings assumption. Against software-infrastructure peers, Oracle's 10.60x PS and 16.80x PB are rich on sales and book, while EV/Sales of 7.58x and EV/EBITDA of 25.06x sit at a premium to typical large-cap infrastructure software; the premium is defensible only if the 29.6% revenue growth and $664 billion backlog are sustained, and the 60.03% gross margin (versus the ~70%+ Oracle historically commanded) argues the business mix is now less software-like and deserves a lower multiple than pure-play SaaS peers. The forward PE of 11.67x versus the trailing 41.78x represents a 72% compression, an unusually aggressive earnings-growth assumption that leaves little room for execution error. Historically, Oracle's PE has ranged from roughly 21.5x (May 2023) to 54.4x (Aug 2025), with recent readings of 42.2x (May 2026) and 23.6x (Aug 2026); at 41.78x trailing, the stock sits in the upper half of its own historical band even after a 59% decline, because earnings have not yet caught up to the price. The PS ratio of 10.60x is well below the 22.9x–42.8x readings of 2025–2026, reflecting the price collapse, but PB of 16.80x remains near the top of its historical range (6.6x–37.5x) due to thin book equity from leverage. Net-net, the valuation is a high-conviction bet on forward earnings materializing: the market is pricing optimistic backlog conversion, and any disappointment would leave the stock expensive on trailing metrics.
PE
41.8x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~42x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.1x
Enterprise Value Multiple
Investment Risk Disclosure
Oracle's financial risk profile has shifted from a cash-cow software company to a leveraged infrastructure builder. TTM free cash flow is -$28.72 billion, with Q1 2027 capex of $28.499 billion consuming 147% of quarterly operating cash flow of $23.103 billion. Debt-to-equity stands at 3.67x, the current ratio is a thin 1.115, and interest expense rose to $1.428 billion in Q1 2027 from $923 million a year earlier. Gross margin has compressed from 67.28% to 60.03% over four quarters as lower-margin cloud infrastructure revenue grows, and the company funded its cash gap with $19.9 billion of stock issuance and $13.1 billion of net financing. These metrics indicate that continued growth is dependent on external capital, and any slowdown in backlog conversion could strain the balance sheet.
Market and competitive risks are amplified by Oracle's premium valuation and high beta. The stock trades at 10.60x PS and 16.80x PB, rich relative to software-infrastructure peers, while EV/EBITDA of 25.06x is at a premium. With a beta of 1.77, Oracle is 77% more volatile than the market, and its 1-year relative strength of -74.56 versus the S&P 500 highlights severe underperformance. Competitive threats include aggressive pricing from hyperscalers like AWS, Azure, and Google Cloud, as well as emerging neoclouds such as CoreWeave, whose recent 15% drop on overcapacity concerns signals potential industry-wide margin pressure. Regulatory headwinds and macro sensitivity—particularly around AI spending—could further compress multiples.
In a worst-case scenario, delayed backlog conversion, continued margin erosion, and financing stress could drive the stock to its 52-week low of $114.50 or the analyst low target of $110.00. From the current price of $128.23, that represents a downside of approximately -10.7% to -14.2%. A more severe scenario, such as a broader AI spending pullback or a credit rating downgrade, could push the stock below its 52-week low, with historical max drawdown of -64.96% illustrating the potential magnitude. Given the 1.77 beta, such a decline could happen rapidly, emphasizing the need for strict risk management.
FAQ
The most severe risk is financial: TTM free cash flow is -$28.7 billion, debt-to-equity is 3.67x, and the current ratio is 1.115, leaving little room for error if backlog conversion slows. Second, margin compression is a major concern, with gross margin falling from 67.3% to 60.0% over four quarters due to lower-margin cloud infrastructure revenue. Third, competitive pressure from hyperscalers and neoclouds could erode pricing power and delay backlog conversion. Fourth, the stock's high beta of 1.77 and 59% one-year decline indicate significant market risk, with a potential downside to the 52-week low of $114.50 (-10.7%) or analyst low target of $110 (-14.2%). These risks are ranked in order of severity, with financial and margin risks being the most immediate.
Our 12-month forecast for ORCL includes three scenarios: a bull case (25% probability) with a target range of $237-$300, assuming successful backlog conversion and margin stabilization; a base case (50% probability) with a target range of $150-$200, assuming gradual conversion and persistent margin pressure; and a bear case (25% probability) with a target range of $110-$130, assuming delayed conversion and financing stress. The base case is most likely, hinging on revenue growth of 20-25% and gross margin stabilizing around 58-60%. The key assumption is that Oracle can convert enough of its $664 billion backlog to offset margin dilution and avoid additional equity issuance.
ORCL's valuation is a tale of two metrics: trailing PE of 41.78x is expensive relative to its historical range (21.5x-54.4x) and the broader market, but forward PE of 11.67x is deeply discounted if earnings estimates are achieved. The market is pricing in a 72% earnings growth assumption, which requires flawless backlog conversion. On a price-to-sales basis, 10.60x is below the 22.9x-42.8x levels of 2025-2026 but still above typical infrastructure software peers. The PEG ratio of 1.26 suggests the growth-adjusted trailing multiple is reasonable. Overall, the stock appears fairly valued on forward earnings but expensive on trailing metrics, implying the market expects significant earnings growth that has yet to materialize.
ORCL is a high-risk, high-reward opportunity that is not suitable for all investors. The stock trades at $128.23, down 59% from its high, with a forward PE of 11.67x that looks cheap if EPS estimates of $27.84 are met. However, negative free cash flow of -$28.7 billion, debt-to-equity of 3.67x, and gross margin compression from 67% to 60% are significant concerns. The analyst consensus is 'buy' with an average target of $237.36, implying 85% upside, but the wide target range ($110-$400) and 1.77 beta indicate high uncertainty. For risk-tolerant investors with a long-term horizon, a small position could be justified as a bet on AI infrastructure growth, but conservative investors should wait for clearer signs of margin stabilization and positive free cash flow.
ORCL is more suitable for long-term investors with a horizon of at least 3-5 years, given the multi-year nature of its cloud backlog conversion and the current negative free cash flow. The stock's high beta (1.77) and recent 59% decline make it unsuitable for short-term trading unless one has a high risk tolerance and uses strict stop-losses. The dividend yield is low at 0.81%, so income is not a primary reason to hold. Earnings visibility is improving with the backlog, but near-term volatility is likely to remain high. A minimum holding period of 3 years is recommended to allow the backlog conversion story to play out and for margins to stabilize.